Previous research in this laboratory, using photoactivatable radioiodinated lipopolysaccharide derivatized with sulfosuccinimidyl-2-4p-azidosalicylamide)-1,3'-dithiopropionate , has resulted in the identification of a specific LPS receptor with a molecular mass of approximately 73 kDa on murine lymphocytes and splenic macrophages. The experiments presented in this report investigated whether a similar LPS-binding protein was also expressed on human peripheral blood populations, including monocytes, lymphocytes, neutrophils, platelets, and erythrocytes. Each cell population was incubated with 125I-ASD-LPS, UV irradiated, washed, reduced, and solubilized, and the cell lysates were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by autoradiography. On all of the cell populations, except erythrocytes, a similar 73-kDa LPS-binding protein was present. In addition, each population also expressed lower-molecular-weight secondary LPS-binding proteins, some of which were conserved among the populations. Binding of the photoactivatable LPS probe was found to be both time and temperature dependent. These data support the concept that the 73-kDa LPS-binding protein is conserved on multiple cell types from a variety of species.
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In spite of the introduction of a large number of effective antibiotics and chemotherapeutic agents, the incidence of gram-negative septicemia has progressively risen since the early 1950s (38) . The current mortality rate associated with gram-negative bacteremia has been estimated to be between 20 and 50% depending upon the age and health status of the patient and the appropriate use of antimicrobial drugs (15) . The prognosis for the bacteremic patient is primarily dependent on whether shock ensues (13) . Septic shock is a syndrome characterized by fever, hypotension, hypoxia, acidosis, and disseminated intravascular coagulation, often leading to multisystem organ failure and death (40) .
The lipopolysaccharide (LPS) of the gram-negative bacterium has been implicated as a major contributing factor to the pathogenesis of septic shock (36) . Of importance, the LPS itself is not toxic, rather it is the ability of the LPS macromolecule to interact with and stimulate a variety of host target cells which subsequently produces the potentially lethal mediators of septic shock (30) . In this respect, experimental evidence accumulated during the last several decades has established that LPS can induce B-cell proliferation and differentiation into antibody-secreting plasma cells (29) . Although endotoxin directly induces proliferation of only a minor subpopulation of T cells (25) , evidence indicates that LPS profoundly affects T-cell responses in mediating its adjuvant properties (23, 24) . Pretreatment of neutrophils with LPS causes a priming effect whereby subsequent stimulation with agents such as N-formyl-methionine-leucinephenylalanine and phorbol myristate acetate results in a marked increase in the oxidative response and granule exocytosis (7) . This priming effect can be augmented to an even greater degree in the presence of platelets, which have recently been reported to secrete a priming factor upon LPS stimulation (44) . Platelet aggregation (35) and serotonin * Corresponding author. release (32) have also been described following LPS stimulation in vitro.
Probably one of the most potentially important responses to LPS, however, occurs following LPS interactions with macrophages and monocytes. These mononuclear phagocytes synthesize and secrete a variety of immunologically relevant cytokines such as alpha/beta interferon (11), interleukin-1 (IL-1) (6), interleukin-6 (IL-6) (39), and tumor necrosis factor (3) in response to LPS stimulation. Strong evidence exists in support of the concept that IL-1, IL-6, and tumor necrosis factor play major roles in mediating the deleterious effects of septic shock (29) ; however, the roles of other host cells should not be understated.
In spite of the fact that LPS is well recognized as a potent stimulus for host inflammatory cells, the precise biochemical mechanisms involved have not, to date, been totally defined. Central to this understanding is the question of specific cellular receptors for LPS. Recent studies by Lei and Morrison (19, 20) For preparation of human platelets, anticoagulated blood was centrifuged at 350 x g at room temperature for 15 min. The platelet-rich plasma was collected and centrifuged at 1,200 x g for 15 min at 10°C to pellet the platelets. The platelets were washed in TBS (pH 6.5; 30 mM Tris, 120 mM NaCl, 5 mM glucose) by centrifugation and then resuspended in TBS (pH 7.4) at a concentration of 107 platelets per ml and placed on ice. Platelet numbers were determined by using an estimate of 3 x 107 platelets per ml of blood drawn.
Following the centrifugation step to obtain the plateletrich plasma, RPMI 1640 (Hazelton Biologics Inc., Lenexa, Kans.) was added to restore the original volume of blood. One volume of 3% dextran (molecular mass, 400 kDa) in 0.9% NaCl was then added, and the tubes were allowed to stand at room temperature for 18 min to sediment RBC. The supernatant containing polymorphonuclear leukocytes (PMN) and mononuclear cells was collected, and the cells were pelleted by centrifugation at 700 x g for 10 min at 4°C and then resuspended in RPMI 1640. Following the dextran sedimentation, RBC Mononuclear cells were obtained from the buffy coat of the gradient. Residual RBC were hypotonically lysed when necessary. The mononuclear cells were washed in RPMI 1640 by centrifugation at 4°C for 10 min at 250 x g. The mononuclear cells were then further fractionated to obtain monocytes and lymphocytes. Briefly, the cells were resuspended at a concentration of 107 cells per ml in RPMI 1640 containing 10% fetal calf serum (Hazelton Biologics) and 1% penicillin-streptomycin (Hazelton Biologics) (100 U/ml and 100 ,ug/ml, respectively). Five to eight milliliters of the cell suspension was plated on a tissue culture dish (100 by 20 mm) (Becton Dickinson, Lincoln Park, N.J.) overnight at 370C to allow adherence of the monocytes. The following day, the nonadherent cell population, containing primarily lymphocytes, was collected, washed in RPMI 1640 by centrifugation at 250 x g for 10 minutes, counted, and placed on ice. The lymphocyte preparation was determined to be approximately 82% CD2+, 6% CD19+, and 0.02% CD14+ by fluorescence-activated cell sorter (FACS) analysis. The adherent monocytes were gently washed with cold Hanks' balanced salt solution without Ca2" or Mg2+ (Hazelton Biologics), and the plate was placed at 4°C for 30 min. The cells were then carefully removed from the plate by using a rubber policeman. The cells were washed with RPMI 1640 by centrifugation at 250 x g for 10 min at 4°C, counted, and placed on ice. The monocyte preparation was determined to be approximately 81% CD14+ and 29% CD2+ by FACS analysis. at 37°C for 30 min exactly as described earlier (19) . No serum was added to any of the reaction mixtures. When indicated, the cell populations were washed and resuspended in RPMI 1640 containing protease inhibitors, (1 mM phenylmethylsulfonyl fluoride, 2 ,ug of aprotinin from bovine lung per ml, 1 ,ug of leupeptin hemisulfate salt per ml, and 1 Vg of alpha-1-antitrypsin from human plasma; all purchased from Sigma) and 5 mM EDTA prior to the addition of the 125I-ASD-LPS.
In some experiments, PMN were pretreated with 0.5 mM diisopropylfluorophosphate (DFP; Sigma) as described by Amrein and Stossel (1) prior to the addition of the I251-ASD-LPS. Following this incubation, the cell suspension was irradiated with short-wavelength UV light (4-W maximal emission at 254 nm) for 10 min to effect covalent association of the LPS with the target cells. cells. Kodak X-Omat XK-1 film and a Dupont cassette with 2 Dupont Cronex Lightning-Plus intensifying screens were used for the autoradiography. The film was exposed to the gel for 1 to 3 days. In some cases, the intensity of the bands on the autoradiographs was determined with a Soft Laser Scanning Densitometer (Biomed Instruments, Inc., Fullerton, Calif.).
RESULTS
We initially assessed the binding of the radiolabeled, photoactivatable, derivatized LPS (125I-ASD-LPS) to human peripheral blood monocytes and lymphocytes. Partially purified cell populations were incubated with 125I-ASD-LPS for 30 min in the dark, UV irradiated, washed, reduced with 2-mercaptoethanol, and analyzed by 11% SDS-PAGE followed by autoradiography. Representative results of these studies are shown in Fig. 1 and 2 . The left-hand panels of these figures show the Coomassie blue-stained protein profiles. The corresponding autoradiographs are shown in the right-hand panels. In these cell populations, an LPS-binding protein of approximately 73 kDa is readily detectable and is similar to that expressed on both of the analogous mouse cell populations and, as reported earlier, on unfractionated human peripheral blood mononuclear cells (37) . Of interest, both populations express several additional lower-molecular-weight LPS-binding proteins, not all of which are equally reactive with LPS in the two cell populations. Particularly noteworthy in the lymphocyte preparation (Fig. 2) the cell populations occurred by virtue of the ASD crosslinking moiety of the LPS probe rather than the LPS, it was important to demonstrate that the binding was specific for LPS. To this end, lymphocytes and monocytes were analyzed exactly as described above except that either a 10-or 50-fold excess of underivatized LPS was added simultaneously with the 125I-ASD-LPS. The results, also shown in Fig. 1 and 2, clearly demonstrate that binding of the derivatized LPS to both the 73-kDa protein and the lower-molecular-weight proteins is specific for the LPS component of the LPS derivatized probe. Addition of increasing concentrations of underivatized LPS effectively competes with the 125I-ASD-LPS for binding to all of the cell populations investigated.
Since it has been well documented that LPS can affect PMN and platelets, it was of interest to investigate whether these peripheral blood cell populations might also express LPS-binding proteins. These populations were purified from normal human blood as described in Materials and Methods and incubated with the 125I-ASD-LPS. The cell lysates were then analyzed by 11% SDS-PAGE followed by autoradiography. The results of these studies are shown in Fig. 3 and 4 . The left-hand panels of each figure again show the Coomassie blue-stained protein profiles, with the corresponding autoradiographs shown in the right-hand panels. As previously demonstrated for the human peripheral blood mononuclear cells, an LPS-binding protein similar to the 73-kDa mouse LPS receptor was expressed on both the platelet and the neutrophil populations. In addition, PMN (Fig. 3) express a number of lower-molecular-weight secondary LPS-binding proteins not detected on any of the other cell types. Platelets (Fig. 4) proteins are not apparent when the higher concentration of platelets is used. However, note that the addition of increasing concentrations of underivatized LPS effectively competes with the 125I-ASD-LPS for binding to both the 73-kDa protein and the lower-molecular-weight proteins on both of these cell populations ( Fig. 3 and 4 that binding of the radiolabeled LPS probe to these lowermolecular-weight proteins is also specific for the LPS portion of the 12 I-ASD-LPS. As shown in Fig. 5 , no LPSbinding proteins were detected on human peripheral blood RBC.
Because a number of secondary lower-molecular-weight LPS-binding proteins were detected on neutrophils and, to a lesser extent, on mononuclear cells, it was possible that these lower-molecular-weight species arose from the proteolytic digestion of the 73-kDa LPS-binding protein. To LPS-binding protein were observed on all of the cell populations (data not shown).
It was also of interest to determine the optimal time required for binding of the 125I-ASD-LPS to the cells. To accomplish this, cells were prepared as described in Materials and Methods and incubated with the 125I-ASD-LPS for 0, 1, 3, 10, or 30 min at 37°C. Following this incubation, the cells were washed and solubilized in SDS sample buffer and analyzed by 11% SDS-PAGE followed by autoradiography. The resulting autoradiographs were then analyzed by densitometric scanning. The densitometric tracings for mononuclear cells and neutrophils are shown in Fig. 8 and 9 , respectively. Binding of the derivatized LPS to the 73-kDa protein was optimal when the incubation was carried out for at least 10 min for all of the cell types. Optimal binding of the LPS probe to the mononuclear cell population (30 min) required additional time as compared with that to the PMN (10 min). In addition, incubation periods of less than 10 min were insufficient for efficient binding of the '25I-ASD-LPS to not only the 73-kDa LPS-binding protein but also to secondary binding proteins present on PMN and mononuclear cells. (12) . Although human platelet responses to LPS have been the subject of some controversy, there is solid evidence that these formed elements can respond to LPS. In this respect, as recently shown by Wright et al. (44) , human PMN responses to LPS can be significantly enhanced by LPS-induced platelet-derived soluble factors. In addition, it has been shown that LPS will markedly enhance the human platelet secretory response to immune complexes and aggregated immunoglobulins (16) .
DISCUSSION
The identification and characterization of LPS receptors on mammalian cells have been complicated by the fact that ILPS can bind nonspecifically to cell membranes. In addition to interactions with membrane phospholipids, it is also possible that binding of LPS to membrane glycoproteins may occur through relatively nonspecific interactions. During the last several years, however, a number of groups have reported the results of experiments designed to identify specific LPS receptors (reviewed in references 8, 18, and 27) . In addition to the results from our laboratory on the p73 LPS-binding protein, proteins of 96 kDa on the macrophage RAW263 cell line (9), 65 and 55 kDa on the macrophage J774 cell line (10), 47 kDa on hepatocytes (34) , and 18 kDa on the mouse 70Z/3 pre-B cell line (14) have been identified. A study published by Dziarski has described a 70-kDa peptidoglycan-binding protein on mouse splenocytes which this investigator also reported binds LPS (5). The latter conclusion has not been confirmed in our own laboratory (22) , and this question remains to be resolved. Further, Wright and Jong (45) In summary, we conclude that many of the human peripheral blood cell populations express an LPS-binding protein with physical and chemical properties similar to a 73-kDa receptor previously identified by our laboratory on mouse lymphocytes and macrophages. In addition, a number of secondary LPS-binding proteins have been identified, and the profiles of these binding proteins appear to be relatively unique for each of the cell populations investigated. The precise role of these proteins in the various cellular responses to LPS remains to be established.
